Dawnrays Pharmaceutical (Holdings) Ltd is an investment holding company. The Company, through its subsidiaries, is principally engaged in the development, manufacture and sale of non-patented pharmaceutical medicines, including intermediate pharmaceutical, bulk medicines and finished drugs. It operates in two segments: intermediates and bulk medicines, and finished drugs. Intermediates and bulk medicines include all the Company鈥檚 chemical and pharmaceutical intermediates and bulk medicines. Finished drugs include all its antibiotic and non-antibiotic finished preparations with dosage forms of powder for injection and solid-dosage-form etc. During the year ended December 31, 2010, the Company obtained three production permits for Lansoproazole Tablets, Entecavir Bulk Medicines and Dispersible Tablets from the State Food and Drug Administration, received 28 supplemental production permits for 16 products, 82 re-registered production permits for 37 products and one clinical permit.